Admescope is a preclinical contract research organization (CRO) providing tailor-made ADME-Tox (Absorption, Distribution, Metabolism, Excretion and Toxicity) services for drug discovery and development companies. Our unique expertise lies in drug metabolism, drug interactions, pharmacokinetics and quantitative bioanalysis, where we stand out with our innovative approach combined with the latest technology. Our services are available for all drug modalities, e.g., small molecules, peptides, oligonucleotides, antibodies and ADCs.
Since 2020, Admescope has been a part of Symeres, with the ability to provide medicinal chemistry and integrated drug discovery & development services through the Symeres organization.
Symeres is the leading mid-sized trans-Atlantic contract research organization for your drug discovery and development needs. With over 600 scientists at several locations (Groningen, Nijmegen, Weert and Oss in the Netherlands, Prague in the Czech Republic, Boston and Princeton in USA and Oulu in Finland) Symeres offers best-in-class solutions for drug discovery and drug development for small molecules and beyond.
The services span from early-stage hit finding all the way to the delivery of your early clinical drug substance API. At Symeres, deep scientific knowledge base is blend with creativity to deliver the quality results your project needs.